Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV · Nasdaq · CIK 0001801170 · Healthcare · Healthcare Plans

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

35 Form 4 transaction lines observed in the same window
29 sales · 6 option, withholding, award, gift or other lines

Last qualifying purchase2025-08-13 · Loengard Anna U · $68.8K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Reynoso Jamie L.CEO, Medicare Advantage
▼▼▼▼▼▼▼▼▼▼▼
Soares KarenChief Legal Officer
▼▼▼○▼
Toy AndrewChief Executive Officer
▼▼▼▼
OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER
▼▼▼
Wai ConradCEO, Counterpart Health
▼▼▼
THORNTON JOSEPH CLAYInterim CFO
▼○▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 2 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-08-13 · Loengard Anna U.

Recent Form 4 activity

0Purchases
35Sales
58Other Form 4 lines
83SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING29 sale line(s) · context only
OTHER6 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
22,900,620
Previous report
23,446,183
Avg daily volume
3,632,140
Days to cover
6.3

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-08-13Loengard Anna UPurchase (P)Class A Common Stock26,500USD 2.59USD 68,755SEC filing ↗
2025-08-08Garipalli VivekPurchase (P)Class A Common Stock31,980USD 2.17USD 69,397SEC filing ↗
2025-08-07Garipalli VivekPurchase (P)Class A Common Stock415,000USD 2.24USD 929,600SEC filing ↗
2024-08-09Garipalli VivekPurchase (P)Class A Common Stock531,700USD 1.88USD 999,596SEC filing ↗
2024-06-17Garipalli VivekPurchase (P)Class A Common Stock877,567USD 1.14USD 1,000,426SEC filing ↗
2024-05-17Loengard Anna UPurchase (P)Class A Common Stock10,000USD 0.93USD 9,300SEC filing ↗
2024-05-16Loengard Anna UPurchase (P)Class A Common Stock17,085USD 0.96USD 16,372SEC filing ↗
2024-03-14Loengard Anna UPurchase (P)Class A Common Stock150,625USD 0.73USD 109,956SEC filing ↗
2023-09-06Loengard Anna UPurchase (P)Class A Common Stock10,500USD 1.30USD 13,650SEC filing ↗
2022-03-11SHAPIRO LEEPurchase (P)Class A Common Stock80,000USD 3.10USD 248,000SEC filing ↗
2022-03-03Clinton ChelseaPurchase (P)Class A Common Stock100,000USD 2.53USD 253,000SEC filing ↗
2021-11-22ChaChaCha SPAC C, LLC; Palihapitiya Chamath; SCH Sponsor III LLCPurchase (P)Class A Common Stock1,739,130USD 5.75USD 9,999,998SEC filing ↗

Form 4 evidence

93 transaction lines in the latest 365-day window; 350 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-07Reynoso Jamie L.Sale (S)Class A Common Stock2,006USD 4.63USD 9,288SEC filing ↗
2026-10-05Reynoso Jamie L.Sale (S)Class A Common Stock8,750USD 4.42USD 38,675SEC filing ↗
2026-10-01Toy AndrewSale (S)Class A Common Stock318,806USD 4.19USD 1,335,797SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-07Reynoso Jamie L.Sale (S)Class A Common Stock2,006USD 4.63USD 9,288SEC filing ↗
2026-10-05Reynoso Jamie L.Sale (S)Class A Common Stock8,750USD 4.42USD 38,675SEC filing ↗
2026-10-01Toy AndrewSale (S)Class A Common Stock318,806USD 4.19USD 1,335,797SEC filing ↗
2026-09-30Torricelli Robert GAward / grant (A)Class A Common Stock12,481USD 0.00USD 0SEC filing ↗
2026-09-30Miller Brian JamesAward / grant (A)Class A Common Stock12,481USD 0.00USD 0SEC filing ↗
2026-09-17Reynoso Jamie L.Sale (S)Class A Common Stock1,921USD 4.56USD 8,760SEC filing ↗
2026-09-16OLDAKOWSKI JOSEPH FRANKSale (S)Class A Common Stock3,170USD 4.64USD 14,709SEC filing ↗
2026-09-15Wai ConradSale (S)Class A Common Stock300,000USD 4.72USD 1,416,000SEC filing ↗
2026-09-15Soares KarenSale (S)Class A Common Stock6,846USD 4.78USD 32,724SEC filing ↗
2026-09-15Reynoso Jamie L.Sale (S)Class A Common Stock9,273USD 4.78USD 44,325SEC filing ↗
2026-09-14OLDAKOWSKI JOSEPH FRANKSale (S)Class A Common Stock20,000USD 5.16USD 103,200SEC filing ↗
2026-08-17THORNTON JOSEPH CLAYSale (S)Class A Common Stock17,775USD 4.39USD 78,032SEC filing ↗
2026-08-12THORNTON JOSEPH CLAYAward / grant (A)Class A Common Stock54,347USD 0.00USD 0SEC filing ↗
2026-08-12Soares KarenAward / grant (A)Class A Common Stock108,695USD 0.00USD 0SEC filing ↗
2026-08-10Toy AndrewSale (S)Class A Common Stock87,798USD 4.65USD 408,261SEC filing ↗
2026-07-20Soares KarenSale (S)Class A Common Stock51,700USD 4.51USD 233,167SEC filing ↗
2026-07-17Reynoso Jamie L.Sale (S)Class A Common Stock4,839USD 4.53USD 21,921SEC filing ↗
2026-07-15Wai ConradSale (S)Class A Common Stock24,215USD 4.67USD 113,084SEC filing ↗
2026-07-15Toy AndrewSale (S)Class A Common Stock62,711USD 4.67USD 292,860SEC filing ↗
2026-07-15THORNTON JOSEPH CLAYSale (S)Class A Common Stock4,630USD 4.67USD 21,622SEC filing ↗
2026-07-15Soares KarenSale (S)Class A Common Stock10,519USD 4.67USD 49,124SEC filing ↗
2026-07-15Reynoso Jamie L.Sale (S)Class A Common Stock13,119USD 4.67USD 61,266SEC filing ↗
2026-07-08Reynoso Jamie L.Sale (S)Class A Common Stock2,384USD 4.68USD 11,157SEC filing ↗
2026-07-06Reynoso Jamie L.Sale (S)Class A Common Stock6,229USD 5.26USD 32,765SEC filing ↗
2026-07-01Toy AndrewSale (S)Class A Common Stock313,476USD 5.32USD 1,667,692SEC filing ↗
2026-06-17Reynoso Jamie L.Sale (S)Class A Common Stock2,360USD 4.78USD 11,281SEC filing ↗
2026-06-16OLDAKOWSKI JOSEPH FRANKSale (S)Class A Common Stock12,102USD 4.86USD 58,816SEC filing ↗
2026-06-15Soares KarenSale (S)Class A Common Stock4,681USD 4.61USD 21,579SEC filing ↗
2026-06-15Reynoso Jamie L.Sale (S)Class A Common Stock6,350USD 4.61USD 29,274SEC filing ↗
2026-06-11Reynoso Jamie L.Sale (S)Class A Common Stock7,289USD 4.91USD 35,789SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCLOV
CIK0001801170
SectorHealthcare
IndustryHealthcare Plans Yahoo Finance
SEC SIC6324 Hospital & Medical Service Plans
ExchangeNasdaq

Data coverage

Local Form 4 history350 transaction lines from 2021-01-07 to 2026-10-07
16 P purchase lines · 48 S sale lines · 286 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.